The pharmaceutical company Double Bond Pharma is carrying out a directed debt set-off issue of approximately SEK 1 million to existing shareholder Investentia, according to a press release.The issue is being carried out within the framework of a previously entered loan agreement of a total of up to SEK 5 million and is used to set off disbursed loans and accrued interest against new B shares.The subscription price has been set at SEK 0.117 per share. The company states that the transaction is intended to strengthen financial flexibility ahead of continued commercial negotiations regarding the drug candidate SI053."This debt set-off issue is a planned step to further strengthen the company's financial flexibility. Through a stronger financial position, our prospects in upcoming negotiations on commercial agreements for our key project SI053 are significantly improved. We see this as an important step to maximize and create the greatest possible long-term shareholder value." says CEO Igor Lokot.